Oppenheimer analyst Michael Wiederhorn maintained a Buy rating on Addus Homecare Corp (NASDAQ: ADUS) today and set a price target of $59. The company’s shares closed yesterday at $52.75, close to its 52-week high of $55.75.
Wiederhorn said:
“We attended meetings with Addus management, including CEO Dirk Allison and CFO Brian Poff. We remain encouraged by the disciplined approach to M&A, the potential upside to the business from recent deals, and the strong outlook to margins from the scale and stable minimum wage trends.”
According to TipRanks.com, Wiederhorn is a top 100 analyst with an average return of 15.0% and a 71.6% success rate. Wiederhorn covers the Services sector, focusing on stocks such as Cross Country Healthcare, Envision Healthcare, and Community Health.
Addus Homecare Corp has an analyst consensus of Moderate Buy, with a price target consensus of $52.67.
See today’s analyst top recommended stocks >>
Addus Homecare Corp’s market cap is currently $613.6M and has a P/E ratio of 43.24. The company has a Price to Book ratio of 3.50.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Addus HomeCare Corp. engages in the provision of in-home personal care services. It includes bathing, grooming, oral care, skincare, assistance with feeding and dressing, medication reminders, meal planning and preparation, housekeeping and transportation services, and other activities of daily living.
